MANHASSET, N.Y.–(BUSINESS WIRE)–Mar 9, 2021–
The American Board of Psychiatry and Neurology (APBN) has named its 2021-2022 Research Award recipients with top honors going to John Q. Young, MD, PhD, of The Feinstein Institutes for Medical Research.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210309005721/en/
John Q. Young, MD, PhD, vice chair for education at Zucker Hillside Hospital (Credit: The Feinstein Institutes for Medical Research).
In an effort to develop a more robust, independent and effective education platform for psychiatry faculty and residents, Dr. Young will use the award to design a competency-based assessment (CBA) system that will help facilitate lifelong learning. Utilizing learning analytics, interactive dashboards and coaching, among other tools, Dr. Young will assess the most impactful tactics to promote longitudinal self-regulated learning (SRL) skills.
“Roughly half of the health care in the United States is outdated in part because physicians take about a decade to incorporate new evidence into their practice. Our medical education and health care systems have failed to produce doctors that are lifelong learners,” said Dr. Young, vice chair for education at Zucker Hillside Hospital. “With the support of the APBN, our research will help identify how best to train physicians who are able to regulate their learning and change their practice as the evidence changes.”
In developing his CBA system, Dr. Young has proposed to include several components:
- Workplace-based assessment;
- Ongoing faculty development;
- Learning analytics;
- Longitudinal coaching;
- Trustworthy clinical competence decision-making processes.
Physicians across all disciplines of medicine must continue their education to stay informed on the most promising medical research, clinical decision making and evidence-based innovations. Through a coaching program and proper assessment system, physicians will learn the educational skills that may stay with them throughout their careers.
“Continuing education is paramount in medicine and science,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes. “Through the APBN’s support, Dr. Young’s research will help advance tools to properly assess continued learning in psychiatry and neurology.”
The American Board of Psychiatry and Neurology, Inc. is a nonprofit corporation dedicated to developing and providing valid and reliable procedures for certification and continuing certification of psychiatrists and neurologists.
About the Feinstein Institutes
The Feinstein Institutes for Medical Researchis the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210309005721/en/
CONTACT: Matthew Libassi
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: BIOTECHNOLOGY OTHER HEALTH HEALTH GENERAL HEALTH ONCOLOGY MENTAL HEALTH OTHER SCIENCE RESEARCH HOSPITALS SCIENCE CLINICAL TRIALS
SOURCE: Northwell Health
Copyright Business Wire 2021.
PUB: 03/09/2021 09:54 AM/DISC: 03/09/2021 09:54 AM